Pathogenic variants in specific ganglioside glycosidases are implicated in several lysosomal storage diseases with neurological manifestations, such as the GM2 and GM1 gangliosidoses, caused by mutations in HEXA/HEXB and GLB1 genes, respectively64. This evidence concerns the gene HEXB and lysosomal storage disease.